Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ascertaining the prognostic role of cardiac resynchronisation therapy in cardiac sarcoidosis: A comparison with ischaemic cardiomyopathy.
Dulay MS, Ahmed R, Liu A, Shi R, Okafor J, Azzu A, Karalis I, Ramphul K, Baksi JA, Wechalekar K, Khattar R, Dar O, Collins P, Wells AU, Kouranos V, Sharma R. Dulay MS, et al. Among authors: karalis i. Curr Probl Cardiol. 2025 Jan;50(1):102892. doi: 10.1016/j.cpcardiol.2024.102892. Epub 2024 Oct 20. Curr Probl Cardiol. 2025. PMID: 39433145 Review.
Predictors of acute kidney injury among octogenarians undergoing open mitral valve repair.
Ali S, Ramphul K, Rahman A, Akkaramani S, Dhaliwal J, Karalis I, Vakali M, Ahmed N, Shahbaz H, Ahmed M, Picker SM, Dhillon S, Ahmad A, Sakthivel H, Shahid F, Ahmed J, Ahmed R. Ali S, et al. Among authors: karalis i. Arch Med Sci Atheroscler Dis. 2024 Jun 22;9:e129-e132. doi: 10.5114/amsad/189732. eCollection 2024. Arch Med Sci Atheroscler Dis. 2024. PMID: 39086620 Free PMC article. No abstract available.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
Procedural and clinical impact of intravascular lithotripsy for the treatment of peri-stent calcification.
van Oort MJH, Al Amri I, Bingen BO, Cordoba-Soriano JG, Karalis I, Sanz-Sanchez J, Oliveri F, van der Kley F, Jukema JW, Jurado-Roman A, Montero-Cabezas JM. van Oort MJH, et al. Among authors: karalis i. Cardiovasc Revasc Med. 2024 Apr;61:16-23. doi: 10.1016/j.carrev.2023.10.013. Epub 2023 Oct 21. Cardiovasc Revasc Med. 2024. PMID: 37923647 Free article.
Evaluation of Reliability and Validity of the RALE and BRIXIA Chest-X Ray Scores in Patients Hospitalized with COVID-19 Pneumonia.
Paraskevas T, Dimopoulos PM, Kantanis A, Garatzioti AS, Karalis I, Michailides C, Chourpiliadi C, Matthaiakaki E, Kalogeropoulou C, Velissaris D. Paraskevas T, et al. Among authors: karalis i. Rom J Intern Med. 2023 May 30;61(3):141-146. doi: 10.2478/rjim-2023-0013. Print 2023 Sep 1. Rom J Intern Med. 2023. PMID: 37249556 Free article.
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients.
Velissaris D, Michailides C, Karalis I, Paraskevas T, Koniari I, Pierrakos C, Karamouzos V. Velissaris D, et al. Among authors: karalis i. Anatol J Cardiol. 2023 May;27(5):232-239. doi: 10.14744/AnatolJCardiol.2023.3023. Anatol J Cardiol. 2023. PMID: 37119193 Free PMC article. Review.
Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?
Michailides C, Paraskevas T, Karalis I, Koniari I, Pierrakos C, Karamouzos V, Marangos M, Velissaris D. Michailides C, et al. Among authors: karalis i. Antibiotics (Basel). 2023 Feb 12;12(2):379. doi: 10.3390/antibiotics12020379. Antibiotics (Basel). 2023. PMID: 36830290 Free PMC article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
71 results